Hemozoin Biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors

School of Biochemistry, Genetics, Microbiology and Plant Pathology, University of KwaZulu-Natal, P.O. Box XO1, Scottsville, 3209, Pietermaritzburg, South Africa.
Parasitology Research (Impact Factor: 2.33). 04/2007; 100(4):671-6. DOI: 10.1007/s00436-006-0313-x
Source: PubMed


Available from: Ernst Hempelmann, Jun 03, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Previous study has confirmed that the occurrence of Wnt pathway activation is associated with risk of non-small-cell lung cancer recurrence. However, whether the pharmacologic blocking of the Wnt signaling pathway could provide therapeutic possibility remains unknown. The aim of the present study was to evaluate the therapeutic functions of the Wnt signaling pathway inhibitor pyrvinium pamoate (PP) on lung cancer stem cells (LCSCs) in vitro. Colony formation and sphere culture were performed to enrich LCSCs from three lung cancer cell lines: PC9, SPC-A1, and A549. After confirming stemness by immunofluorescence, PP was employed for cell viability assay by comparison with three other kinds of Wnt signaling inhibitor: salinomycin, ICG-001, and silibinin. The effect of PP on LCSCs was further verified by colony formation assay and gene expression analysis. LCSCs were successfully generated by sphere culture from SPC-A1 and PC9 cells, but not A549 cells. Immunofluorescence assay showed that LCSCs could express pluripotent stem cell markers, including NANOG, Oct4, KLF5, and SOX2, and Wnt signaling pathway molecules β-catenin and MYC. Half-maximal inhibitory concentrations of PP on SPC-A1, PC9, and A549 were 10 nM, 0.44 nM, and 0.21 nM, respectively, which are much lower than those of salinomycin, ICG-001, and silibinin. Moreover, significantly decreased colony formation and downregulation of pluripotent stem cell signaling pathway were observed in lung cancer cells after treatment with PP. Wnt signaling inhibitor PP can inhibit proliferation of LCSCs, and the Wnt signaling pathway could be considered a promising therapeutic or interventional target in lung adenocarcinoma.
    Drug Design, Development and Therapy 01/2015; 9:2399-407. DOI:10.2147/DDDT.S76602 · 3.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Effect a synthetic Aluminium-Magnesium Silicate (AMS) has on chloroquine was tested. Thirty, Plasmodium berghei-infected mice, in three experimental groups (7 mg/kg, 5 mg/kg and 3 mg/ kg) of 10 mice each, were treated. Two sub-groups, in each experiment, were treated with chloroquine and with a chloroquine-AMS drug formulation, respectively. Five of the infected mice served as controls. Parasitaemia (%), Hae-moglobin concentration (Hb), Red Blood Cells (RBC), rectal temperature and body weight were assessed. Parasitaemia of subgroups treated at 7 mg/kg were higher than that of the control. Also, at 7 mg/kg, there was mortality with chloroquine (20%) and with the chloroquine-AMS drug (80%). At 5 mg/kg and 3 mg/kg, the AMS significantly (P < 0.05) improved ability of chloroquine to reduce plamodial parasitaemia, from 2.46 ± 0.21 to 1.57 ± 0.25 and from 3.82 ± 0.06 to 2.12 ± 0.08. It also significantly (P < 0.05) improved means of Hb and RBC from 12.25 ± 0.27 and 88.99 ± 5.72 to 12.68 ± 0.18 and 92.91 ± 4.01 and from 10.18 ± 3.00 and 63.39 ± 18.02 to 12.98 ± 0.47 and 95.23 ± 5.32. Body weight increased at 5 mg/kg, from 29.06 ± 1.95 to 32.66 ± 2.10 kg (P < 0.05) while at 3 mg/kg, rectal temperature reduced from 37.35 ± 0.32 to 36.84˚C ± 0.23˚C (P < 0.05). These results suggest, AMS worsened chloroquine toxicity at 7 mg/kg but potentiated its antiplasmodial activities at the lower doses.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Malaria remains as one of the significant health threat to people living in countries throughout tropical and subtropical zones. Proteomic studies of Plasmodium, the protozoan causing malaria, is essential for understanding its cellular structure, growth stage-specific expression of protein metabolites and complex interaction with host. In-depth knowledge of the pathogen is required for identification of novel biomarkers that can be utilized to develop diagnostic tests and therapeutic antimalarial drugs. The alarming rise in drug-resistant strains of Plasmodium has created an urgent need to identify new targets for drug development that can act by obstructing life cycle of this parasite. In the present review, we briefly discuss on role of various biomarkers including Plasmodium-associated aldolase, histidine-rich proteins and lactate dehydrogenase for diagnosis of malaria. Here we also summarize the present and future prospects of currently used techniques in proteomic approaches such as two dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) for diagnosis and potential identification of novel proteins for malaria research. Copyright © 2015 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.
    Asian Pacific Journal of Tropical Medicine 04/2015; 419(4). DOI:10.1016/S1995-7645(14)60327-8 · 0.93 Impact Factor

Similar Publications